Laquinimod

NERVOUS SYSTEM

Also known as: ABR-215062 sodium, laquinimod sodium, nerventra, TV-5600

Ministry of Health of the Russian Federation approvedATC N07XX10

Data last refreshed: 2026-11-10 (DrugCentral release 2024-11-01)

Open interactive profile (3D, safety, PGx)

Key facts

Laquinimod is a drug catalogued in DrugCentral. It was first approved by the Ministry of Health of the Russian Federation in 2013. Recorded indications include Relapsing remitting multiple sclerosis.

Indications: Relapsing remitting multiple sclerosis.
ATC code: N07XX10 (Other nervous system drugs).
Molecular formula: C19H17ClN2O3; molecular weight 356.81 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

Relapsing remitting multiple sclerosis

Regulatory approvals (1)

Date	Agency	Marketed as	Applicant	Orphan
2013-07-05	Ministry of Health of the Russian Federation	—	Teva

ATC classification

ATC code	Therapeutic hierarchy
`N07XX10`	NERVOUS SYSTEM › OTHER NERVOUS SYSTEM DRUGS › OTHER NERVOUS SYSTEM DRUGS › Other nervous system drugs

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Laquinimod is on its molecule page.

Molecular formula	C₁₉H₁₇ClN₂O₃
Molecular weight	356.81 g/mol
CAS number	248282-07-7
InChIKey	GKWPCEFFIHSJOE-UHFFFAOYSA-N
PubChem CID	54677946

CCN(C(=O)C1=C(O)C2=C(C=CC=C2Cl)N(C)C1=O)C1=CC=CC=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Laquinimod used for?

DrugCentral lists the following indications for Laquinimod: Relapsing remitting multiple sclerosis.

When was Laquinimod first approved?

Laquinimod was first approved by the Ministry of Health of the Russian Federation in 2013.

What is the chemical formula of Laquinimod?

Laquinimod has the molecular formula C19H17ClN2O3 and a molecular weight of 356.81 g/mol.

Browse: all drugs starting with L · drug guides by category · protein targets A–Z.

Sources

DrugCentral drug card 4825 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
ChEMBL CHEMBL2103814 — compound record and bioactivity
PubChem CID 54677946 — chemical identifiers
DrugBank DB06685 — drug record
FDA UNII 908SY76S4G — substance identity

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.